How does vitamin B6 interact with levodopa therapy?

How does vitamin B6 interact with levodopa therapy?

• A. Increases absorption
• B. Increases rate of aromatic amino acid decarboxylation
• C. Inhibits metabolism
• D. Decreases distribution

Answer: (B)

Vitamin B6 serves as a cofactor for DOPA decarboxylase (aromatic L-amino acid decarboxylase), the enzyme that converts L-DOPA to dopamine. In levodopa therapy, a significant portion of L-DOPA can be decarboxylated in peripheral tissues before it reaches the brain. When vitamin B6 is present, it speeds up this peripheral decarboxylation, reducing the amount of L-DOPA that enters the CNS and thus diminishing the therapy’s effectiveness. If a peripheral decarboxylase inhibitor like carbidopa is used, this peripheral step is blocked, so vitamin B6 no longer enhances decarboxylation in the periphery. Vitamin B6 does not increase absorption, inhibit metabolism, or affect distribution in this context.

Vitamin B6 serves as a cofactor for DOPA decarboxylase (aromatic L-amino acid decarboxylase), the enzyme that converts L-DOPA to dopamine. In levodopa therapy, a significant portion of L-DOPA can be decarboxylated in peripheral tissues before it reaches the brain. When vitamin B6 is present, it speeds up this peripheral decarboxylation, reducing the amount of L-DOPA that enters the CNS and thus diminishing the therapy’s effectiveness. If a peripheral decarboxylase inhibitor like carbidopa is used, this peripheral step is blocked, so vitamin B6 no longer enhances decarboxylation in the periphery. Vitamin B6 does not increase absorption, inhibit metabolism, or affect distribution in this context.